PB2353: HEALTHCARE RESOURCE UTILIZATION AND COSTS OFF THERAPY WITH FIXED-DURATION VENETOCLAX AMONG CLL PATIENTS - J. N. Allan; A. P. Skarbnik; N. Emechebe; H. Alhasani; B. S. Manzoor (HemaSphere, 2022)